<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Nine patients with <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> showing 10% or more positive blast cells with platelet peroxidase (<z:chebi fb="1" ids="53262">PPO</z:chebi>) or CD41b were diagnosed as megakaryoblastic <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Three patients transformed from <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> or <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:chebi fb="1" ids="53262">PPO</z:chebi> positivity ranged from 7 to 55% (median 45%), and that for CD41b was 1.6 to 67.0% (median 16.4%) </plain></SENT>
<SENT sid="3" pm="."><plain>Because electron microscopic myeloperoxidase or glycophorin A were also positive in some patients, and also because CD41b positivity was often discordantly lower than <z:chebi fb="1" ids="53262">PPO</z:chebi> positivity, a possibility of mixed <z:hpo ids='HP_0001909'>leukemia</z:hpo> demonstrating myeloid or erythroid differentiation was suggested in 6 of these cases </plain></SENT>
<SENT sid="4" pm="."><plain>As for the treatment results, <z:hpo ids='HP_0000001'>all</z:hpo> 3 pediatric cases who received combination chemotherapy achieved complete remission (CR) </plain></SENT>
<SENT sid="5" pm="."><plain>Among 6 adult cases CR was obtained in only one patient to whom low-dose <z:chebi fb="1" ids="16040">cytosine</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi> was administered </plain></SENT>
<SENT sid="6" pm="."><plain>The remaining adult patients who received combination chemotherapy died relatively early </plain></SENT>
</text></document>